Two COVID-19 vaccines being tested in the UK have moved on to the third phase of trials, marking a significant step forward in the development process.
One of the vaccines, Novavax, will be tested on around 10,000 participants aged between 18 and 84 years over the next four to six weeks.
To read more, click here: https://trib.al/kpjEz1u
SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews
Follow us on Twitter: https://twitter.com/skynews
Like us on Facebook: https://www.facebook.com/skynews
Follow us on Instagram: https://www.instagram.com/skynews
For more content go to http://news.sky.com and download our apps:
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí https://www.youtube.com/channel/UCzG5BnqHO8oNlrPDW9CYJog